TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 42 filers reported holding TRINITY BIOTECH PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,262 | -23.8% | 1,732,395 | +0.5% | 0.26% | -21.0% |
Q2 2023 | $1,657 | -1.5% | 1,724,000 | -2.9% | 0.32% | -10.0% |
Q1 2023 | $1,682 | -7.0% | 1,775,100 | -2.7% | 0.36% | -17.4% |
Q4 2022 | $1,809 | -99.9% | 1,823,633 | +1.5% | 0.44% | -11.9% |
Q3 2022 | $1,910,000 | -13.3% | 1,797,190 | -0.6% | 0.50% | -8.8% |
Q2 2022 | $2,202,000 | -13.9% | 1,808,533 | -25.0% | 0.54% | -34.0% |
Q1 2022 | $2,557,000 | -21.8% | 2,412,116 | +5.5% | 0.82% | -12.0% |
Q4 2021 | $3,269,000 | -27.8% | 2,286,150 | +9.1% | 0.94% | -35.7% |
Q3 2021 | $4,527,000 | -25.1% | 2,095,900 | +2.0% | 1.46% | -22.7% |
Q2 2021 | $6,044,000 | -2.2% | 2,055,700 | +25.1% | 1.88% | +31.8% |
Q1 2021 | $6,178,000 | -3.6% | 1,642,959 | -2.3% | 1.43% | -9.4% |
Q4 2020 | $6,407,000 | +84.7% | 1,681,650 | -2.0% | 1.58% | +63.5% |
Q3 2020 | $3,468,000 | -4.5% | 1,716,600 | +3.0% | 0.96% | -10.7% |
Q2 2020 | $3,632,000 | +111.8% | 1,666,100 | +6.9% | 1.08% | +62.3% |
Q1 2020 | $1,715,000 | +12.2% | 1,558,900 | +5.4% | 0.66% | +40.0% |
Q4 2019 | $1,529,000 | -15.1% | 1,479,500 | -0.6% | 0.48% | -23.3% |
Q3 2019 | $1,801,000 | -23.9% | 1,488,810 | +3.8% | 0.62% | -24.0% |
Q2 2019 | $2,366,000 | -23.0% | 1,434,110 | +33.0% | 0.81% | -24.3% |
Q1 2019 | $3,074,000 | +37.8% | 1,078,610 | +10.8% | 1.08% | +18.6% |
Q4 2018 | $2,230,000 | -32.3% | 973,682 | +18.3% | 0.91% | -20.2% |
Q3 2018 | $3,293,000 | -14.9% | 823,223 | +6.3% | 1.14% | -18.7% |
Q2 2018 | $3,871,000 | +0.5% | 774,258 | +3.6% | 1.40% | -2.8% |
Q1 2018 | $3,850,000 | +6.1% | 747,481 | +5.1% | 1.44% | +7.6% |
Q4 2017 | $3,627,000 | +0.9% | 711,185 | +10.9% | 1.34% | -4.6% |
Q3 2017 | $3,596,000 | -0.1% | 641,011 | +6.9% | 1.40% | -4.2% |
Q2 2017 | $3,598,000 | +29.9% | 599,600 | +29.0% | 1.46% | +25.6% |
Q1 2017 | $2,770,000 | -3.9% | 464,750 | +11.6% | 1.16% | -5.3% |
Q4 2016 | $2,882,000 | -41.5% | 416,500 | +11.8% | 1.23% | -41.9% |
Q3 2016 | $4,927,000 | +62.9% | 372,677 | +39.8% | 2.12% | +61.6% |
Q2 2016 | $3,024,000 | +122.5% | 266,658 | +128.8% | 1.31% | +111.0% |
Q1 2016 | $1,359,000 | +272.3% | 116,550 | +275.4% | 0.62% | +288.1% |
Q4 2015 | $365,000 | +158.9% | 31,050 | +152.4% | 0.16% | +142.4% |
Q3 2015 | $141,000 | -40.0% | 12,300 | -5.4% | 0.07% | -32.7% |
Q2 2015 | $235,000 | -6.0% | 13,000 | 0.0% | 0.10% | 0.0% |
Q1 2015 | $250,000 | +42.9% | 13,000 | +30.0% | 0.10% | +46.3% |
Q4 2014 | $175,000 | -4.4% | 10,000 | 0.0% | 0.07% | -5.6% |
Q3 2014 | $183,000 | – | 10,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prospect Capital Advisors, LLC | 336,550 | $3,924,000 | 4.65% |
ACK Asset Management | 979,600 | $11,422,000 | 4.49% |
Balter Liquid Alternatives, LLC | 161,284 | $1,881,000 | 4.33% |
GOLDMAN CAPITAL MANAGEMENT INC | 396,690 | $4,625,000 | 3.50% |
Paradice Investment Management LLC | 1,435,724 | $16,741,000 | 2.23% |
Adirondack Research & Management Inc. | 415,353 | $4,843,000 | 1.76% |
Lapides Asset Management, LLC | 705,100 | $8,221,000 | 1.47% |
Park West Asset Management LLC | 900,000 | $10,494,000 | 0.99% |
Benchmark Capital Advisors | 83,541 | $974,000 | 0.86% |
HEARTLAND ADVISORS INC | 1,290,010 | $15,042,000 | 0.79% |